| Active substance |
Meldonium |
| Also known as |
Mildronate |
| Blood pressure |
Can cause fluctuations, generally lowering blood pressure |
| Chemical name |
3-(2,2,2-trimethylhydraziniumyl)propionate |
| Dosage |
500-1000 gm/day |
| Dosage (medical) |
Typically 500-1000 mg per day, divided into two doses |
| Dosage (sports) |
Often 500 mg per day |
| Effects |
Increases blood flow, improves exercise capacity, and facilitates cardiac rehabilitation |
| FORM |
60 caps x 500 mg |
| Formula |
C6H14N2O2 |
| Half-life |
4-6 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Detectable in blood and urine tests |
| Main action |
Improves metabolism and energy supply of tissues |
| Side effects |
May include headache, dizziness, indigestion, heart rate changes, and anxiety |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Substance class |
Metabolic modulator |
| Trade name |
Mildronate, among others |
| Use in sports |
Banned by the World Anti-Doping Agency (WADA) as a performance-enhancing drug |
| Water Retention |
No significant effect |
| Manufacturer |
Grindex |
